No Data
Zhejiang Xianju Pharmaceutical (002332.SZ): The high-end formulation project has entered the equipment installation and debugging stage.
Gelonghui, December 23丨Zhejiang Xianju Pharmaceutical (002332.SZ) stated on the investor interactive platform that the high-end formulation project has entered the equipment installation and debugging stage. The company's goodwill was formed in the consolidated balance sheet after the acquisition of 100% equity of the Italian companies Newchem and Effechem in 2017.
The One-year Shareholder Returns and Company Earnings Persist Lower as Zhejiang Xianju PharmaceuticalLtd (SZSE:002332) Stock Falls a Further 9.4% in Past Week
Zhejiang Xianju Pharmaceutical (002332.SZ) intends for two products to be selected in the tenth batch of national Pharmaceutical centralized procurement.
Zhejiang Xianju Pharmaceutical (002332.SZ) announced that the company participated in the national organization on December 12, 2024...
Zhejiang Xianju Pharmaceutical (002332.SZ): Sugammadex Sodium Injection and Methionine Sulfate Neostigmine Injection are expected to be selected for centralized procurement.
Gelonghui, December 13th: Zhejiang Xianju Pharmaceutical (002332.SZ) announced that on December 12, 2024, the company participated in the bidding for the 10th batch of national centralized pharmaceutical procurement organized by the National Organization for Drug Procurement Office. The company's products, Sugengutong Sodium Injection and Methanesulfonate Neostigmine Injection, are intended to be selected for this centralized procurement.
Is Zhejiang Xianju Pharmaceutical Co.,Ltd.'s (SZSE:002332) Recent Performance Tethered To Its Attractive Financial Prospects?
gf sec: The upstream prices of penicillin and cephalosporins are fluctuating at a high level, while the active pharmaceutical ingredient is finding a bottom and stabilizing.
According to the data from the National Bureau of Statistics, in September 2024, the month-on-month PPI value of chemical drug active pharmaceutical ingredient manufacturing was 97.10, an increase of 2.0 compared to the previous month, and an increase of 1.63 from the average of 95.47 in the first half of 2024. Since the year 2023, when the month-on-month PPI of active pharmaceutical ingredient manufacturing fell below 100 for the whole year, the recent PPI value has been in an increasing state, indicating that the overall price of active pharmaceutical ingredients is in a phase of slight bottoming and recovery.
Little Excitement Around Zhejiang Xianju Pharmaceutical Co.,Ltd.'s (SZSE:002332) Earnings As Shares Take 27% Pounding
